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1. Introduction 
There is now abundant evidence that a variety of 
cell surface stimuli can provoke an increased turnover 
of phosphorylinositol group of phosphatidylinositol 
(PI-effect) through specific receptor mechanism(s) 
[ 1,2] . Such a phenomenon isreported to occur both 
in neural and non-neural tissues in response to physio- 
logical and pharmacological stimuli [ 1 ] . Recently I have 
shown an increased turnover of phosphatidylinositol in 
rat superior cervical ganglia (SCG)* and in pineal gland 
in response to nerve growth factor (NGF) [3,4] . This 
protein has been implicated in the growth and survival of 
sympathetic neurones through all ages [5] . Stimula- 
tion of PI breakdown in rat SCG and in pineal is 
reported to be mediated by acetylcholine and nor- 
adrenaline r spectively, through their specific receptor 
systems [6-81. However, the PIeffect elicited by 
NGF in rat SCG is found to be insensitive to both 
nicotinic and muscarinic receptor blockers. In pineal 
glands o-adrenergic receptor blockers did not prevent 
the NGF specific PI turnover. Moreover, the NGF 
specific PI effect is observed in bilaterally decen- 
tralized superior cervical ganglia s well as in pineals, 
after bilateral superior cervical ganglionectomy [4] . 
These studies uggested that the PI-effect observed in 
response to NGF in both organs may indicate a post- 
synaptic site of action of NGF. The present study was 
undertaken with a view to obtaining a better under- 
standing of the site of action of NGF in these organs. 
Abbreviations: NGF, nerve growth factor; SCG, superior 
cervical ganglia; PI, phosphatidylinositol; 6-OHDA, 
6-hydroxydopamine; TH, tyrosine hydroxylase 
Elsevier/North-Holland Biomedical Press 
2. Experimental 
Nerve growth factor (NGF) 2.5 S was prepared 
from male mouse submaxillary glands according 
to the method of Bocchini and Angeletti [9] . 
6-Hydroxydopamine (6-OHDA) Hbr. was obtained 
from Roche Laboratories, Nutley, NJ. Culture 
medium and antibiotics were obtained from Grand 
Island Biological Co., NY. All other chemicals were 
of reagent grade. 
A total of 64 newborn rats were used for these 
studies. Pregnant animals were housed in single cages. 
As soon as they delivered, each litter was reduced to 
eight pups and subdivided into two groups. Each 
group received injection subcutaneously from day 2 
through day 9 as follows. The first group received 
one injection of 100 I.tl of saline containing 1 mg/ml 
of ascorbic acid. The second group received 100 ccg/g 
body weight of 6-OHDA freshly prepared in saline 
containing 1 .O mg/ml of ascorbic acid. The solution 
was kept under nitrogen atmosphere during the 
period of injection. The pups were sacrificed 48 h 
after the last injection. Superior cervical ganglia nd 
pineal glands removed from both groups were organ 
cultured as described elsewhere [3] . Briefly pairs 
of ganglia or pineal glands were placed in 250 ~1 of 
BGJb medium, FittonJackson modification without 
phenol red. The medium was supplemented with 
0.1% bovine serum albumin. Fraction V and an 
antibiotic mixture which included penicillin 
(100 U/ml), and streptomycin (100 I.cg/ml). Ascorbic 
acid (0.1 mg/ml) and glutamine (2 mM) were prepared 
and added just before use. Appropriate concentration 
of NGF diluted in BGJb medium was added in 5 /.d 
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volume. The incubation started with the addition of 
labelled myoinositol and the tissues were maintained 
at 37’C in tissue culture clusters in a humidified 
atmosphere of 95% oxygen and 5% carbon dioxide 
for the desired length of time. At the end of incuba- 
tion, the tissues were removed and rinsed in normal 
saline containing 10 -4 M unlabelled myoinositol. 
Then pairs of ganglia or pineal glands were homoge- 
nized in 4 ml of chloroform-methanol mixture 
(2: 1, v/v). The lipid extract was washed four times 
with 0.2 volume of normal saline containing lo4 M 
unlabelled myoinositol, transferred to scintillation 
vials and dried under a stream of nitrogen. They were 
counted in the presence of scintillation cocktail 
(5 g PPO and 0.5 g of POPOP for 100 ml toluene). 
3. Results 
Newborn rats, which had been treated daily with 
6-OHDA from day 2 through day 9, did not show 
any gross change in their external appearance. A low 
incidence of mortality was noticed. Body weights 
were slightly reduced compared to saline-ascorbic 
acid treated rats. A marked decrease in the size of 
superior cervical ganglia was evident under dissection 
microscope. The pineal glands of 6-OHDA treated 
rats appeared to be normal in size. Table 1 shows the 
effect of NGF on the incorporation of labelled 
myoinositol into phosphatidylinositol in SCG removed 
from sham treated and 6-OHDA treated rats. The 
addition of NGF (1 X 10-s M) stimulated the incor- 
poration of myoinositol into PI about 57% in SCG 
removed from sham treated rats suggesting an 
increased PI turnover in response to NGF. A marked 
increase of 125% stimulation was observed in SCG 
removed from 6-OHDA treated rats. However, the 
SCG of the latter group showed a marked decrease in
their basal PI turnover compared to that of sham 
treated rats. This decrease could be due to the reduc- 
tion in the number of neuronal cells as a result of 
6-OHDA treatment [lo] . As shown in table 2 NGF 
elicited about 62% stimulation of PI turnover in sham 
treated rats whereas 55% stimulation was observed in 
pineal glands removed from 6-OHDA treated rats. 
However, very little difference was noticed in the 
basal turnover of PI of pineal glands of the two 
groups. 
4. Discussion 
Increased turnover of phosphatidylinositol in 
response to hormones and putative neurotransmitters 
is now widely documented. This phenomenon is
probably mediated at the cell surface through specific 
receptor mechanism(s) [l] . In rat SCG, NGF induced 
‘PI-effect’ appears to be a receptor specific event [3] . 
No other hormone could substitute for NGF. The PI- 
effect is demonstrable in physiological range of con- 
Table 1 
Effect of 6-OHDA treatment on nerve growth factor induced PI turnover in rat SCG 
__ _-- .-- 
Additions to Sham treated SCG 6-OHDA-treated SCG 
culture 
[“HIP1 Stimu- [ “HIP1 Stimu- 
dpm/pair SCG lation dpm/pair SCG lation 
None 270 + 24 - lOOk 12 - 
[1180 f 1051 (625 * 751 
NGF (1 X lo-” M) 425 i 30a 57% 225 f 20a 125% 
[ 1860 f 1301 [1406 f 1251 
- 
a P<O.Ol compared to control. The value in parentheses represents dpm/mg 
protein 
Pairs of superior cervical ganglia of immature rats were organ cultured for 20 h in 
the presence of 12.5 PCi [ 2-3H] myoinositol (spec. activity 2 Ci/mmol) as described 
in text. Each value represents the mean f SE from 12 pairs of SCG 
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Table 2 
Effect of 6-GHDA treatment on nerve growth factor induced 
PI turnover in rat pineal 
Additions to 
culture 
Sham treated pineal 6_OHDA-treated pineal 
(‘HIP1 Stimu- [ ‘HIP1 Stimu- 
(dpm/pineal) lation (dpm/pmeal) lation 
None 220* 22 - 200* 18 - 
[1403 f 1401 [1220 f 1101 
NGF (1 X lo-” M) 356 f 30a 62% 310* 24a 55% 
[2271 + 1901 (1892 f 1461 
a P<O.Ol compared to control. The value in parentheses represents dpm/mg 
protein 
Pairs of pineal glands of immature rats were organ cultured for 20 h in the pres- 
ence of 12.5 &i of [ 2-3H] myoinositol (spec. activity 2 Ci/mmol) as described in 
text. Each value represents the mean * SE of at least twelve pineal glands 
centration of NGF. Also NGF specific ‘PI-effect’ is 
sensitive to NGF antibody. We have also presented 
evidence elsewhere for the probable site of action of 
NGF 141. NGF specific PI turnover was found to be 
insensitive to various neurotransmitter receptor 
specific blockers. Surgical denervation did not 
abolish the PI-effect in rat SCG and in pineal glands. 
These results indicated that the PI-effect in response 
to NGF might occur on the post-synaptic structures. 
In the present paper, we have made use of the proper- 
ty of 6-OHDA to extend and confirm our earlier 
findings. 
6-OHDA treatment in newborn rats not only 
destroys adrenergic nerve terminals but also produces 
widespread lesions in the cell body of these neurones 
[ 1 l] . In rat SCG, 6-OHDA treatment is also known 
to decrease neuronal cell population without affecting 
the supporting cells [lo] . The addition of NGF did 
elicit a ‘PI-effect’ in SCG and in pineal of 6-OHDA 
treated rats. Thus it is conceivable from the results 
that the NGF-specific PI turnover is on the post- 
synaptic structures both in pineal and SCG, and in 
the case of ganglia, the site may be localized on the 
neuronal perikaryon. Another aspect of the results 
presented in this paper deserves comment, namely, 
the enhanced stimulation (125%) of NGF specific 
‘PI-effect’ in SCG of 6-OHDA treated rats compared 
to the stimulation (57%) observed in SCG of sham 
treated rats. It appears that the 6-OHDA treatment 
does potentiate the ‘NGF receptor’ specific PI turn- 
over. This is interesting in the light of the report by 
Levi-Montalcini et al. [ 121 that the combined treat- 
ment of NGF and 6-OHDA, versus NGF alone, 
resulted in a paradoxical volume increase of SCG and 
a much larger increase of total as well as the specific 
activities of TH in the ganglia. During a short time 
in vivo uptake studies, Levi-Montalcini et al. [ 131 
also noticed a greater accumulation of “‘1-NGF in the 
cell bodies of sympathetic neurones of rats subjected 
for two weeks period to dual NGF and 6-OHDA 
treatment, in contrast to NGF or saline treatment. 
Thus the results presented in this paper, taken 
together with the findings of Levi-Montalcini et al. 
[ 131, led to suggest hat 6-OHDA treatment to new- 
born rats results in an increased NGF-receptor density 
on the cell body of adrenergic neurones. Such an 
alteration in the NGF receptor density could be inter- 
preted as a fine control mechanism for the survival of 
neurones against the cytotoxic action of 6-OHDA. 
Alternatively the lack of evidence for the increased 
receptor density in pineal after 6-OHDA treatment, 
means that this organ does not need NGF for its 
ultimate survival. 
Further work in progress includes (a) elucidation 
of the functional significance of PI turnover, (b) 
whether the increased NGF-receptor density after 
6-OHDA treatment is a permanent or a transient 
feature of adrenergic neurones, and (c)how this 
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property could be used as a tool to isolate and 
identify the NGF receptor molecules. 
[3] Lakshmanan, J. (1978) Biochem. Biophys. Res. 
Commun. in press. 
[4] Lakshmanan, J. (1978) submitted for publication. 
[5] Levi-Montalcini, R. and Angeletti, P. U. (1968) Physiol. 
Acknowledgement 
I thank Drs A. Jamaluddin, P. S. Sastry and 
P. V. Reddy for critical reading of the manuscript, 
Dr P. Balaram for his interest and CSIR for financial 
support. 
Rev. 48,534-569. 
[6] Larrabee, M. G. and Leicht, W. S. (1965) J. Neurochem. 
12,1-13. 
[7] Pickard, M. R., Hawthorne, J. N., Hayashi, E. and 
Yamada, S. (1977) Biochem. Pharm. 26,448-450. 
[8] Hauser, G., Shein, H. M. and Eichberg, J. (1974) Nature 
252,482-483. 
[9] Bocchini, V. and Angeletti, P. U. (1969) Proc. Natl. 
Acad. Sci. USA 64,787-794. 
References 
[ 1] Michell, R. H. (1975) Biochim. Biophys. Acta 415, 
81-147. 
[2] Hawthorne, J. N. (1973) in: Form and Functions of 
Phospholipids (Ansell, G. B., Dawson, R. M. C. and 
Hawthorne, J. N., eds) pp. 423-440, Elsevier, 
Amsterdam. 
[lo]’ Aloe, L., Mugnaini, E. and Levi-Montalcmi, R. (1975) 
Arch. Ital. Biol. 113,326-353. 
[ll] Angeletti, P. U. and Levi-Montalcini, R. (1970) Proc. 
Natl. Acad. Sci. USA 65,114-121. 
[ 121 Levi-Montalcini, R., Aloe, L., Mugnaini, E., Oesch, F. 
and Thoenen, H. (1975) Proc. Natl. Acad. Sci. USA 72, 
595-599. 
[ 131 Levi-Montalcini, R., Menisenichen, M. G., Chen, J. S. 
(unpublished) cited by Levi-Montalcini, R. (1976) Adv. 
Biochem. Psychopharmacol. 15,237-250. 
162 
